Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Aripiprazole Sandoz Aripiprazole 5mg Tablet Novartis New Zealand Limited Sandoz Private Limited, Navi Mumbai, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Aripiprazole Sandoz Aripiprazole 10mg Tablet Novartis New Zealand Limited Sandoz Private Limited, Navi Mumbai, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Aripiprazole Sandoz Aripiprazole 15mg Tablet Novartis New Zealand Limited Sandoz Private Limited, Navi Mumbai, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Aripiprazole Sandoz Aripiprazole 20mg Tablet Novartis New Zealand Limited Sandoz Private Limited, Navi Mumbai, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Aripiprazole Sandoz Aripiprazole 30mg Tablet Novartis New Zealand Limited Sandoz Private Limited, Navi Mumbai, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Vecure Vecuronium bromide 10mg Powder for injection Mylan New Zealand Limited Mylan Laboratories Limited, Bangalore, India
|
Dated this 15th day of February 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013)